Revenue from operations during the quarter was up by 6.7 per cent to Rs 6,407.10 crore against Rs 6,002.2 in the same period last fiscal.
Profit after Tax stood at Rs. 106 crore as compared to Rs. 84 crore registering growth of 26%
The Survey highlighted that Indian pharmaceutical exports achieved a healthy growth of 24 per cent in FY21 and expressed hope that India’s domestic pharmaceutical market is estimated to grow to US $65 billion by 2024 from estimated US $41 billion in 2021
Multilateral collaborations will serve to strengthen knowledge sharing to formulate framework for accessible, affordable, and quality healthcare
The top 15 Indian pharma players have continued to experience anaemic growth in the US market over the five years ended FY22
Moderna and Merck announced mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a 44% reduction in the risk of disease recurrence or death in melanoma patients
India now has 648 medical colleges in 2022 with a whopping 96% increase in the number of Government Medical Colleges (GMC) alone and a 42% increase in the private sector, since 2014
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
Expressed happiness that more than 30 countries of the world have given recognition to Ayurveda as a traditional system of medicine
Application includes data from key phase III trials, including the pivotal MOMENTUM trial, which met all primary and key secondary efficacy endpoints
Subscribe To Our Newsletter & Stay Updated
